Anna Eshoo actually said...

"I am proud of the bipartisan work, but it is critical that we recognize that the work cannot and will not stop there."

"the rising drug costs and need for greater transparency in the whole chain."

"To the manufacturers, again: Are there any other fees or monies that are associated with manufacturers and PBMs that I have missed?"

"I still don't quite get it but I want to move on to my next question."